DOI QR코드

DOI QR Code

The Role of Aviation Medical Examiners in the Diagnosis, Treatment and Aeromedical Assessment of Patients with Allergic Rhinitis

알레르기 비염 진단 및 치료, 항공업무 적합성 평가에 있어 항공전문의사의 역할

  • Kim, Young Hyo (Inha Institute of Aerospace Medicine, Inha University School of Medicine)
  • 김영효 (인하대학교 우주항공의과학연구소)
  • Received : 2020.08.06
  • Accepted : 2020.08.13
  • Published : 2020.08.31

Abstract

Since allergic rhinitis is a disease with a very high prevalence, it is common to find patients with allergic rhinitis among aviation workers. However, they are so afraid that the report of rhinitis will have a negative effect on the evaluation of one's work suitability. Therefore, aviation medical examiners (AMEs) must be able to accurately understand the nature of allergic rhinitis, and confidently explain that appropriate treatment of rhinitis has a positive effect on their performance. In the treatment of allergic rhinitis, there are some medications that may cause drowsiness, which may impair the accuracy and safety of the aviation service. Therefore, AMEs should accurately know safe drugs that do not cause drowsiness and prescribe them to patients. In addition, it is necessary to know exactly whether air workers may receive the latest treatments for allergic rhinitis, such as surgical treatment and immunotherapy, and be able to recommend these treatments appropriately. Therefore, in this paper, we first briefly describe the pathophysiology, genetics, causative antigen, symptoms, diagnosis, and treatment of allergic rhinitis. We also aimed to discuss safe medication and other treatment modalities for allergic rhinitis.

Keywords

Acknowledgement

This study was supported by the Ministry of Education, Science, and Technology through the National Research Foundation of Korea (NRF2018R1A6A1A03025523).

References

  1. Ahn KM, Kim JY, Kwon HJ, Chae YM, Hahm MI, Lee KJ, et al. The prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in Korean children: nationwide cross-sectional survey using complex sampling design. J Korean Med Assoc 2011;54(7):769-778. https://doi.org/10.5124/jkma.2011.54.7.769
  2. Broide DH. Allergic rhinitis: Pathophysiology. Allergy Asthma Proc 2010;31(5):370-374. https://doi.org/10.2500/aap.2010.31.3388
  3. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63 Suppl 86:8-160. https://doi.org/10.1111/j.1398-9995.2007.01620.x
  4. Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR, et al. Clinical practice guideline: Allergic rhinitis. Otolaryngol Head Neck Surg 2015;152(1 Suppl):S1-43.
  5. Costa DJ, Bousquet PJ, Ryan D, Price D, Demoly P, Brozek J, et al. Guidelines for allergic rhinitis need to be used in primary care. Prim Care Respir J 2009;18:250-257. https://doi.org/10.4104/pcrj.2009.00028
  6. Mandhane SN, Shah JH, Thennati R. Allergic rhinitis: an update on disease, present treatments and future prospects. Int Immunopharmacol 2011;11:1646-1662. https://doi.org/10.1016/j.intimp.2011.07.005
  7. Wilson AM, O'Byrne PM, Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med 2004;116:338-344. https://doi.org/10.1016/j.amjmed.2003.10.030
  8. Cobanoglu B, Toskala E, Ural A, Cingi C. Role of leukotriene antagonists and antihistamines in the treatment of allergic rhinitis. Curr Allergy Asthma Rep 2013;13:203-208. https://doi.org/10.1007/s11882-013-0341-4
  9. Benninger MS, Ahmad N, Marple BF. The safety of intranasal steroids. Otolaryngol Head Neck Surg 2003;129:739-750. https://doi.org/10.1016/j.otohns.2003.10.001
  10. Brooks CD, Karl KJ, Francom SF. Oral methylprednisolone acetate (Medrol Tablets) for seasonal rhinitis: examination of dose and symptom response. J Clin Pharmacol 1993;33:816-822. https://doi.org/10.1002/j.1552-4604.1993.tb01957.x